Shanghai – Talk Bio

Actionable Insights Powered by AI

Roche Pledges Nearly $300M to Establish New Vabysmo Production Plant in China

4 weeks ago talkbio0Tagged Biopharmaceutical manufacturing, China, Disorder of eye, green energy, Investments, localization, plant construction, Roche (company), Shanghai, Vabysmo

Roche; Vabysmo; biopharmaceutical manufacturing; Shanghai; China; investment; eye disease treatment; plant construction; localization; green energy

HUTCHMED Divests 45% Stake in Shanghai Hutchison Pharmaceuticals for $608 Million to Focus on Core Oncology Pipeline

5 months ago talkbio0Tagged antibody-targeted therapy, ATTCs, HUTCHMED, Immunostimulating conjugate (antigen), Oncology Pipeline, profitability, Shanghai, Strategic Focus

HUTCHMED, Shanghai Hutchison Pharmaceuticals, divestment, oncology pipeline, antibody-targeted therapy conjugates (ATTCs), strategic focus, profitability.